State Lawmakers Hold Hearing on Effects of EpiPen Price Hike

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

The California state Senate Health Committee held a hearing in downtown Los Angeles to gather testimony regarding the dramatic price increase in the EpiPen, the drug used to treat life-threatening allergies. Asked for comment, the company that makes the pen, Mylan Pharmaceuticals, pointed KTLA to its CEO's Sept. 21 testimony to a U.S. congressional committee. Chris Wolfe reports from downtown Los Angeles for the KTLA 5 News at 1 on Sept. 29, 2016.